Filter posts

The Real Reason Why Salk Refused to Patent the Polio Vaccine

Editor’s Note: Despite the progress in polio and other diseases made possible by vaccines, today …

IBM's Watson: From Jeopardy! to Drug Research

Bits of technology from I.B.M.’s Watson are beginning to be used in actual products available …

Where's the Deal?

With only two weeks to go in 2011 it is looking like a five year …

Diabetes and Biotechnology: A Shared History…A Great Future

By David Welch, President/Senior Producer at M2 MultiMedia One of my closest childhood friends suffered from …

Drug Discovery & Development: Partnering for Success...and Survival

There are pressures on Big Pharma and biotech emerging companies alike to engage in more …

Breast Cancer and Biotechnology: Bigger Than Pink

By David Welch, President/Senior Producer at M2 MultiMedia It had been five years since I …

Repositioning Drugs for Parkinson's Disease

Last month, The Michael J. Fox Foundation (MJFF) announced the launch of its Repositioning Drugs …

Beyond the ABCs of ADCs

The recent FDA approval of Seattle Genetics’ antibody, Adcetris, has cast the spotlight on Antibody …

Developing Cancer Therapies and Diagnostics: 4 Pieces of Advice

Insights in to the molecular and genetic basis of disease are driving new product and …

Perspective on Market Valuation for Biotech Drug Developers

Of the 300 publicly traded U.S. biotechs, 219 (73%) are developing drugs. The other 27% …